AUSTIN, TX--(Marketwire - Nov 21, 2011) - EPIC Corporation (PINKSHEETS: EPOR) (the "Company"), announced its plan for the next 12 months, reaffirmed its stock dividend, and shareholders and prospective investors can download the Company's Statement of Information & Annual Report as of September 30, 2011, which includes Financial Statements for the years ending September 30, 2011and 2010, from the Company's website.

The Company will commence selling the SOMNUS Sleep Pad™ and the MIT 1000A with Micro Imaging Technology's bacterial libraries, Listeria, E.coli, Salmonella, and MRSA. In order to obtain funds the Company intends to liquidate some of its investments.

The Company, in order to create greater liquidity in stock trading and to continue its policy of providing shareholders with stock or cash dividends, reaffirms its stock dividend of one share of common stock for each share owned by shareholders of record as of February 28, 2012, which is an extension from December 30, 2011. On the date of this release there are 12,797,363 shares issued and outstanding with 1,760,020 in the float. Payment is to be on or before March 31, 2012. As of that date there will be 25,594,726 shares issued and outstanding and 3,520,040 shares in the float. This assumes that no additional shares have been issued prior to the record date or additional shares being deposited with a broker dealer.

A summary of the Company's Balance Sheet as of September 30, is as follows:

2011 2010
Current Assets $ 35,209 $ 18,627
Other Assets $ 2,445,566 $ 1,976,311
Accrued Interest $ 112,825 $ 0
Contingent Liability 500,000 0
Loans Payable - Convertible Notes 795,585 72i6,267
Stockholders Equity $ 1,072,273 $ 1,247,127

EPIC's mission is to provide people with better healthcare. For information about EPIC Corporation click this link:

Contact Information:

Ronald Tucker
Email Contact
Telephone: (760) 771-0036